Brazilian scientist Dr. Tatiana Coelho Sampaio and her team have spent more than two decades researching polylaminin, a laboratory-engineered form of laminin, a protein that helps nerve cells connect and grow. Their goal is to repair damaged spinal cords and restore lost movement.
In an early pilot clinical study involving eight patients with acute, complete spinal cord injuries, two participants died from the severity of their injuries shortly after enrollment, according to the researchers. Among the six surviving patients, all regained some voluntary motor control below the level of their spinal injury after receiving the experimental treatment.
These findings are remarkable because complete spinal cord injuries rarely recover significant motor function on their own. However, it's important to note that this research is still experimental. The study has not yet gone through large-scale clinical trials, and scientists emphasize that more testing is needed to confirm how safe and effective the treatment is before it can become a standard therapy.
If future trials continue to show positive results, this research could transform the treatment of spinal cord injuries and offer hope to millions of people living with paralysis worldwide.
0 commentaires:
Enregistrer un commentaire